LLY80:BKK
Eli Lilly And Company KTB DR
1,98 ฿
arrow_upward
+1,54%(+0,030) 1D
13 tet, 1:50:12 p.d., GMT+7 · THB
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për LLY80...
Hap
1,98 ฿
I lartë
1,99 ฿
I ulët
1,94 ฿
Kapitalizimi i tregut
1,11 bln
Vëllimi mesatar
5,19 mln
Vëllimi
2,46 mln
Maksimumi 52-javor
2,12 ฿
Minimumi 52-javor
1,27 ฿
Aksionet në qarkullim
941,36 mln
Numri i punonjësve
50 mijë
Hap
1,98 ฿
I lartë
1,99 ฿
I ulët
1,94 ฿
Kapitalizimi i tregut
1,11 bln
Vëllimi mesatar
5,19 mln
Vëllimi
2,46 mln
Maksimumi 52-javor
2,12 ฿
Minimumi 52-javor
1,27 ฿
Aksionet në qarkullim
941,36 mln
Numri i punonjësve
50 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
The Globe and Mail
·
3 orë më parë
4 Healthcare Stocks Worth Owning for the Next Decade
Investing.com Canada
·
4 orë më parë
RBC Capital reiterates Eli Lilly stock rating on incretin momentum By Investing.com
The Motley Fool
·
5 orë më parë
This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock
marketscreener.com
·
5 orë më parë
Eli Lilly Likely to Raise Revenue Outlook Amid Strong Diabetes, Weight-Loss Drug Sales, RBC Says
Profili
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Rreth Eli Lilly And Company KTB DR
Drejtori ekzekutivDavid A. Ricks
Punonjësit50 mijë
Themeluar më1876
SeliaIndianapolis, Indiana, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtililly.com